These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 88744)

  • 21. Activity of the cytomegalovirus genome in the presence of PPi analogs.
    Wahren B; Rudén U; Gadler H; Oberg B; Eriksson B
    J Virol; 1985 Dec; 56(3):996-1001. PubMed ID: 2999452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic evidence for vaccinia virus-encoded DNA polymerase: isolation of phosphonoacetate-resistant enzyme from the cytoplasm of cells infected with mutant virus.
    Moss B; Cooper N
    J Virol; 1982 Aug; 43(2):673-8. PubMed ID: 7109036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trisodium phosphonoformate, a new antiviral compound.
    Helgstrand E; Eriksson B; Johansson NG; Lannerö B; Larsson A; Misiorny A; Norén JO; Sjöberg B; Stenberg K; Stening G; Stridh S; Oberg B
    Science; 1978 Sep; 201(4358):819-21. PubMed ID: 210500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology and chemistry of some inhibitors of herpes replication.
    Fox BW
    J Antimicrob Chemother; 1977 Mar; 3 Suppl A():23-32. PubMed ID: 324967
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition by phosphonoacetate of the in vitro outgrowth of Epstein-Barr virus genome-containing cell lines from the blood of infectious mononucleosis patients.
    Rickinson AB; Finerty S; Epstein MA
    IARC Sci Publ (1971); 1978; (24 Pt 2):721-8. PubMed ID: 221394
    [No Abstract]   [Full Text] [Related]  

  • 26. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
    Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N
    Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity studies on phosphonoacetate.
    Mao JC; Otis ER; von Esch AM; Herrin TR; Fairgrieve JS; Shipkowitz NL; Duff RG
    Antimicrob Agents Chemother; 1985 Feb; 27(2):197-202. PubMed ID: 2984985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of action of foscarnet against viral polymerases.
    Crumpacker CS
    Am J Med; 1992 Feb; 92(2A):3S-7S. PubMed ID: 1371038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foscarnet therapy for AIDS-related opportunistic herpesvirus infections.
    Jacobson MA
    AIDS Clin Rev; 1992; ():173-89. PubMed ID: 1318736
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of African swine fever (ASF virus replication by phosphonoacetic acid.
    Moreno MA; Carrascosa AL; Ortín J; Viñuela E
    J Gen Virol; 1978 May; 39(2):253-8. PubMed ID: 650176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effect of phosphonoacetic acid on early antigen synthesis in two Epstein-Barr virus producer cell lines.
    Patel P; Menezes J
    Virology; 1979 Jan; 92(1):236-9. PubMed ID: 217163
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro suppression of Herpesvirus saimiri replication by phosphonoacetic acid.
    Barahona H; Daniel MD; Bekesi JG; Fraser CE; King NW; Hunt RD; Ingalls JK; Jones TC
    Proc Soc Exp Biol Med; 1977 Mar; 154(3):431-4. PubMed ID: 191845
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased efficacy of phosphonoformate and phosphonoacetate inhibition of herpes simplex virus type 2 replication by encapsulation in liposomes.
    Szoka FC; Chu CJ
    Antimicrob Agents Chemother; 1988 Jun; 32(6):858-64. PubMed ID: 2843083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of disodium phosphonoacetate and iododeoxyuridine on the multiplication of African swine fever virus in vitro.
    Gil-Fernández C; Páez E; Vilas P; Gancedo AG
    Chemotherapy; 1979; 25(3):162-9. PubMed ID: 378573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.
    Reno JM; Lee LF; Boezi JA
    Antimicrob Agents Chemother; 1978 Feb; 13(2):188-92. PubMed ID: 206200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Non-nucleoside antiherpetic agents].
    Nishiyama Y
    Nihon Rinsho; 1989 Feb; 47(2):390-4. PubMed ID: 2470934
    [No Abstract]   [Full Text] [Related]  

  • 37. Basic biochemical and pharmacological aspects of antiviral agents.
    Prusoff WH; Zucker M; Mancini WR; Otto MJ; Lin TS; Lee JJ
    Antiviral Res; 1985; Suppl 1():1-10. PubMed ID: 3002248
    [No Abstract]   [Full Text] [Related]  

  • 38. [Etiological therapeutics in viral diseases].
    Brochier B; Thiry E; Wérenne J; Schwers A; Vindevogel H; Pastoret PP
    Ann Rech Vet; 1984; 15(1):35-54. PubMed ID: 6207760
    [No Abstract]   [Full Text] [Related]  

  • 39. Aranucleosides and aranucleotides in viral chemotherapy.
    North TW; Cohen SS
    Pharmacol Ther; 1979; 4(1):81-108. PubMed ID: 88745
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of phosphonoacetic acid on the ultrastructure of cell cultures infected with simian oncogenic herpesviruses.
    King NW; Barahona H; Daniel MD; Bekesi G; Jones TC
    Lab Invest; 1978 Feb; 38(2):181-8. PubMed ID: 203772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.